Sign in

eBioMedicine – The Lancet Discovery Science

@ebiomedicine.bsky.social
474 followers 31 following 52 posts

Leading biomedical #openaccess journal, bridging the gap between basic and clinical research. Part of The Lancet Discovery Science. IF=10.8 🌐 www.thelancet.com/journals/ebiom/ho…

PostsRepliesMedia
Reposted by eBioMedicine – The Lancet Discovery Science
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 28/09/2026
Published in @ebiomedicine.bsky.social Metabolomic profiling of ultra-processed food consumption and #cardiovascular risk in Spanish preschool children: a cross-sectional study www.thelancet.com/journals/ebi... #UPFs #CVD #OpenAccess #MedSky #EndoSky #CardioSky
thelancet.com
Metabolomic profiling of ultra-processed food consumption and cardiovascular risk in Spanish preschool children: a cross-sectional study
In Spanish pre-schoolers UPF-related metabolomic profiles were associated with different cardiovascular risk factors. These diet-related metabolomic scores capture biological correlates relevant to ea...
042
Reposted by eBioMedicine – The Lancet Discovery Science
MedUni Wien @meduniwien.ac.at · 25/09/2026
🫁 Sensitisation patterns in respiratory #allergies – children vs. adults A study coordinated by #MedUniVienna shows that sensitisation to house dust mites is more common in children, whereas sensitisation to outdoor #pollen allergens is more common in adults. ⬇️ 📰 @ebiomedicine.bsky.social​
meduniwien.ac.at
Respiratory allergies: Children are more likely to react to house dust mites, whilst adults react to pollen
Find out more!
032
Reposted by eBioMedicine – The Lancet Discovery Science
APC Microbiome Ireland @apcmicrobiomeirel.bsky.social · 16/09/2026
Gut signals may track brain age. A 1,462-person 𝐄𝐁𝐢𝐨𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 study links brain age, cognition and gut biology. With APC authors. MAEVE studies polyphenols and cognition in Alzheimer’s-risk adults. Read: buff.ly/GfkSlPV APC: buff.ly/IyoMZoV #Microbiome @jfcryan.bsky.social @ebiomedicine.bsky.social
Announcement of a new scientific publication showing a link between gut microbiome/metabolites and accelerated brain ageing, featuring a journal article preview, a right-hand summary panel with the key finding, institutional logos, and three researchers' headshots.
234
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 25/08/2026
Azithromycin is one of the last effective oral treatments for typhoid. But azithromycin-resistant S. Typhi strains have emerged — new @oucru.bsky.social research shows it likely can't cure infections they cause. 🦠📢 www.thelancet.com/journals/ebi... @duy-pham-lab.bsky.social @ox.ac.uk #AMR #Typhoid
thelancet.com
Determining intracellular and extracellular activities of azithromycin against azithromycin-resistant Salmonella Typhi and their association with clinical treatment responses
We have established a THP-1 macrophage model to characterise the intracellular pharmacodynamics of azithromycin. Our findings indicate that azithromycin is likely ineffective for treating infections c...
011
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 12/08/2026
🆕The August issue of eBioMedicine is now live! 📰 Cover art by Magdalena Żebrowska from Eva S. Schernhammer's group.
Illustrated brain divided into warm and cool halves, with glowing neural networks, a central clock, an EEG-like wave, and a DNA strand.
030
Reposted by eBioMedicine – The Lancet Discovery Science
eClinicalMedicine – The Lancet Discovery Science @eclinicalmed.bsky.social · 04/08/2026
📢Register now for our free #Webinar "Transforming the Landscape of #GynaecologicalCancer: Advances in Prevention, Precision Surgery, and Innovative Systemic Therapies" on Sept 3: irc.ad/the-lancet-g... Read the linked Series here: thelancet.com/series-do/gy... @chrustrasbourg.bsky.social
087
Reposted by eBioMedicine – The Lancet Discovery Science
MedUni Wien @meduniwien.ac.at · 07/08/2026
📈 What improves long-term success after #kidneytransplant? A #MedUniVienna study shows that beyond HLA tissue compatibility, genome-wide genetic compatibility matters and introduces a score to better predict rejection risk and personalise #immunosuppressivetherapy. ⬇️ 📰 @ebiomedicine.bsky.social​
meduniwien.ac.at
Genome-wide tissue matching improves the prediction of long-term success following kidney transplantation
Read more!
081
Reposted by eBioMedicine – The Lancet Discovery Science
MedUni Wien @meduniwien.ac.at · 22/07/2026
Why do some people find it easier than others to lose the rhythm of their #internalclock? 🧬⏰ A study led by #MedUniVienna shows that susceptibility to circadian imbalance is based on the interplay of several genetically influenced traits. ⬇️ 📰 @ebiomedicine.bsky.social #CircadianRhythm​
meduniwien.ac.at
Genetic basis of susceptibility to circadian rhythm disruption investigated
Read more about the study!
062
Reposted by eBioMedicine – The Lancet Discovery Science
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 13/07/2026
Published in @ebiomedicine.bsky.social Transcriptomics of type 1 #diabetes progression: a validation study in newly diagnosed patients www.thelancet.com/journals/ebi... #T1D #genetics #INNODIA #OpenAccess #MedSky #EndoSky #GeneticsSky
thelancet.com
Transcriptomics of type 1 diabetes progression: a validation study in newly diagnosed patients
These findings support the existence of biological heterogeneity in disease progression after diagnosis of type 1 diabetes and contribute to an improved understanding of the molecular dynamics associa...
011
Reposted by eBioMedicine – The Lancet Discovery Science
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 13/07/2026
Published in @ebiomedicine.bsky.social Off-label #testosterone therapy is associated with higher long-term #cardiovascular risk in men www.thelancet.com/journals/ebi... #OpenAccess #MedSky #EndoSky
thelancet.com
Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men
The cardiovascular safety of TT appears context-dependent and less favourable when treatment is initiated without evidence of hypogonadism, with clinically relevant heterogeneity across race/ethnicity...
012
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 08/07/2026
🚨 July issue! In “Decoding the host–microbiome dialogue with biological foundation models,” the editorial asks why microbiome therapies fail to translate—and calls for moving from association to mechanistic, function-level prediction, with careful validation. #Microbiome #AI #TranslationalResearch
121
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 01/07/2026
We are an internationally trusted journal for translational #BiomedicalResearch and review, with a: • Journal Impact Factor of 11·2 • Scopus CiteScore of 19·1 Explore our high impact and global reach: hubs.li/Q04k_D8c0 #TranslationalMedicine #OpenAccess
110
Reposted by eBioMedicine – The Lancet Discovery Science
Barcelonaβeta Brain Research Center @barcelonabeta.bsky.social · 19/06/2026
🧠 A new BBRC-led study published in @ebiomedicine.bsky.social shows that blood biomarkers may help rule out Alzheimer’s disease pathology in people with subjective memory complaints. This could support earlier & accessible clinical decision-making in people with subjective cognitive decline.
131
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 10/06/2026
Only ~1 in 500 seizure-focus spikes propagate to the thalamus during sleep—yet thalamic activity still predicts surgical failure in #FocalEpilepsy. New research in eBioMedicine helps explain why.
Cover of eBioMedicine, Volume 128 (June 2026). The layout features a clean white background with a scientific illustration at the bottom. Text headings list: an editorial on patient-derived organoid models, an article on thalamic interictal events during NREM sleep in focal epilepsy, and a review on intrathecal gene therapy for neurological disorders. The journal branding and website appear at the top.
100
Reposted by eBioMedicine – The Lancet Discovery Science
Marvin Petersen @petersenm.bsky.social · 02/06/2026
New paper out in The Lancet @ebiomedicine.bsky.social on the oral–brain axis 🦷🧠. Does the bacterial community living in our gum pockets relate to brain health? In 1,026 people from the population-based PAROMIND cohort, we show the answer is yes. 🧵 #neuroskyence #microbiome #dementia
thelancet.com
Subgingival microbiota composition is associated with brain health in the general population–the PAROMIND study
These findings from a large cohort advance the understanding of the oral microbiome–brain axis, highlighting specific microbial profiles linked to subclinical cognitive, structural, and inflammatory b...
1158
Reposted by eBioMedicine – The Lancet Discovery Science
Jan Wenzel @janwenzel.bsky.social · 30/05/2026
Happy to share our new publication on the role of endothelial cells in age-related cognitive dysfunction, published in @ebiomedicine.bsky.social. Thanks to all coauthors, incl. Dimitrios Spyropoulos, @dorotheazi.bsky.social, @talongden.bsky.social, and many more. www.thelancet.com/journals/ebi...
thelancet.com
Lancet
022
Reposted by eBioMedicine – The Lancet Discovery Science
Abishek Arora, PhD @aroraneuro.bsky.social · 28/05/2026
📣 Excited to share our recent paper that investigates how different SSRIs have an impact on the metabolism of neural cells 🧠 Please read our popular science summary at @ki.se web: news.ki.se/new-study-sh... 🧪 The publication is open access at @ebiomedicine.bsky.social, DOI: doi.org/10.1016/j.eb...
news.ki.se
New study shows how different SSRIs affect metabolism in early brain development
A new study from Karolinska Institutet shows that different SSRI medications affect metabolic processes in developing nerve cells in distinct ways. Alterations in energy metabolism, oxidative stress a...
131
Reposted by eBioMedicine – The Lancet Discovery Science
Tsinghua University @tsinghuauniversity.bsky.social · 25/05/2026
Are you getting enough vitamin B7? A recent #InnovativeTsinghua study by Assoc. Prof. Ai Zhao’s team, featured in @ebiomedicine.bsky.social, shows that adequate dietary biotin intake is linked to a lower risk of all-cause #dementia and #Alzheimer’s disease. For more: bit.ly/4lDMpge
011
Reposted by eBioMedicine – The Lancet Discovery Science
ashleyginda.bsky.social @ashleyginda.bsky.social · 17/05/2026
Excited to share this labor of love on the dynamics of CD4 T cells in HIV infection—now published in @ebiomedicine.bsky.social ! www.thelancet.com/journals/ebi...
thelancet.com
Clonal dynamics of HIV-infected and uninfected T cells
Our longitudinal analysis of HIV sequences suggests that a subset of HIV-infected cells may divide and die faster than uninfected T cells, contributing to a dynamic reservoir.
022
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 14/05/2026
📣 Sudden cardiac death is a devastating and potentially avoidable cause of premature mortality. The pilot of a #NHS #genomics centred pathway demonstrates how health systems can systematically identify and manage population-level risk of #suddencardiacdeath. @thebhf.bsky.social @cryuk.bsky.social
tinyurl.com
Prospective use of genomics in the evaluation of sudden cardiac death: results from a national health service population pathway
Integration of coronial, pathology, genomic, and cardiac services in a prospective population pathway enabled efficient capture and use of genetic and clinical information to reduce population risk of...
000
Reposted by eBioMedicine – The Lancet Discovery Science
Brain Network Dynamics Unit @bndu.ox.ac.uk · 13/05/2026
New unit paper on "Dynamic neural states underpin motor symptom severity in Parkinson's disease: a longitudinal analysis of chronic cortico-subthalamic nucleus recordings", published in @ebiomedicine.bsky.social. www.bndu.ox.ac.uk/papers/dynam... @rnd.ac.uk @ndcnoxford.bsky.social @ox.ac.uk
Cartoon image of a person with Parkinson's on left, with a plot of brainwaves, and classification of neural states on right.
021
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 13/05/2026
🧬 New issue of eBioMedicine Across infectious, neurological, and complex systemic diseases, the studies in this issue use molecular and genetic analyses to clarify mechanisms underlying observed clinical outcomes.
Illustrated cover of eBioMedicine showing a large pair of lungs with branching airways, oversized pills, and two clinicians studying the lungs—one using a microscope from a ladder and another taking notes while standing on stacked books. Cover lines mention long COVID, community-acquired pneumonia, and Alzheimer’s and Parkinson’s disease research.
101
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 07/05/2026
New research from @neuroecologylab.bsky.social @oxcin.bsky.social helps address the large between-species gap that currently exists in #TranslationalNeuroscience by building a mouse-to-human brain translational model from gene expression. Read #openaccess now 👇
thelancet.com
Translating brain anatomy and disease from mouse to human in latent gene expression space
Our work provides i) a quantitative bridge across evolutionary divergence between the human and the predominant preclinical species, ii) a predictive framework to help design and evaluate disease mode...
053
Reposted by eBioMedicine – The Lancet Discovery Science
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 28/04/2026
Published in @ebiomedicine.bsky.social Insights into the genetic aetiology of diabetes in Africa www.thelancet.com/journals/ebi... #diabetes #genetics #Africa #OpenAccess #MedSky #EndoSky #GeneticsSky
thelancet.com
Insights into the genetic aetiology of diabetes in Africa
Despite the high public health burden of diabetes in Africa, research into its genetic aetiology has been slow, limiting the continent's ability to benefit from an emerging era of diabetes precision m...
021
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 14/04/2026
Metabolic dysfunction is a risk factor for neurodegeneration, but do Alzheimer’s and Parkinson’s share the same underlying biology? 🧠 New research suggests they do not, pointing to fundamentally different metabolic-genetic architectures. #Alzheimers #ParkinsonsDisease #Neurodegeneration
tinyurl.com
Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap
AD and PD are shaped by fundamentally distinct metabolic-genetic architectures. Metabolically targeted interventions, particularly those modulating lipid, amino acid, and proglucagon pathways, may require disease-specific and genetically informed strategies for prevention and treatment of neurodegenerative diseases.
011
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 08/04/2026
📢 New Issue Alert. The latest eBioMedicine issue is out now—featuring cutting-edge #TranslationalResearch across #GlobalHealth, #AI, #neuroscience, #oncology & more. 🔬 From maternal–fetal health to AI in clinical research, explore new insights shaping the future of medicine.
001
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 20/03/2026
A new study shows that tumour homologous recombination deficiency profiles can help classify uncertain BRCA1/2 variants in #breastcancer. Using WGS from 350 breast tumours, the CHORD algorithm provided the most precise gene-specific predictions. Full text🔗: www.thelancet.com/journals/ebi...
001
Reposted by eBioMedicine – The Lancet Discovery Science
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 11/03/2026
Published in @ebiomedicine.bsky.social Sleep apnea, heart health and testosterone: unravelling the triad of well-being www.thelancet.com/journals/ebi... #OpenAccess #MedSky #EndoSky #CardioSky
thelancet.com
Sleep apnea, heart health and testosterone: unravelling the triad of well-being
Sleep disorders, cardiovascular diseases (CVDs), and hormonal imbalances, particularly with respect to testosterone levels, are closely interconnected and significantly impact public health. This revi...
142
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 11/03/2026
📢 The March 2026 issue of eBioMedicine is live! This month brings advances in cancer biology, neuroscience, immune pathways, gut physiology, the microbiome, and maternal–fetal health. 🔗 Read the full issue online: www.thelancet.com/journals/ebi...
120
Reposted by eBioMedicine – The Lancet Discovery Science
Jennifer Juno @jenjuno.viralvaxlab.com · 03/03/2026
🎉 Our new study of CD4 TFH quality is now online @ebiomedicine.bsky.social! We know that TFH are critical for germinal centres and antibody production, but want to understand whether all CD4 responses can be equally helpful to B cells. www.thelancet.com/journals/ebi...
thelancet.com
Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
Our findings emphasise the importance of CD4+ T cell help for programming robust and durable humoural immunity, and provide crucial insights to guide the rational incorporation of favourable T cell ep...
1134
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 27/02/2026
🌍 Ahead of #RareDiseaseDay, reflections from the 5th @crick.ac.uk Rare Disease Conference: although each rare condition affects few people, 300M+ individuals worldwide live with a rare disease. Delayed diagnosis, limited treatments, and fragmented care remain major challenges.
120
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 18/02/2026
🥱😴 Sleep matters: a new eBioMedicine series on sleep health unveils how sleep, cardiometabolic health, hormones, and pain intersect across the lifespan. The 2 open-access reviews highlight mechanisms, clinical implications, and opportunities for integrated care.
102
Reposted by eBioMedicine – The Lancet Discovery Science
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 12/02/2026
Published in @ebiomedicine.bsky.social Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion www.thelancet.com/journals/ebi... non-functioning #adrenal #tumours #Cushing's syndrome #OpenAccess #MedSky #EndoSky
thelancet.com
Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion
MACS represents a metabolic continuum between NFAT and adrenal CS. Increased activity of the adrenal enzyme 11β-hydroxylase (CYP11B1), which catalyses key steps in cortisol and 11-oxygenated androgen ...
031
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 11/02/2026
🚨 The February 2026 issue of eBioMedicine is now live. This month’s Editorial tackles a central question in longevity science and modern medicine: Can biological age be measured in a way that meaningfully improves clinical care? 🔗 All open access content here: www.thelancet.com/issue/S2352-...
101
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 10/02/2026
People are living with disease while waiting for research to become care. The @britishneuro.bsky.social Festive Symposium highlighted that the ethical duty of translational neuroscience now extends beyond discovery itself. Delivery is part of the science. 🔗 www.thelancet.com/journals/ebi...
thelancet.com
End-to-end translation in neuroscience
The British Neuroscience Association (BNA) Festive Symposium 2025, held on December 9, 2025, set out to examine what it really means for neuroscience to reach society. Rather than focussing on discove...
013
Reposted by eBioMedicine – The Lancet Discovery Science
Michael Biehl @michaelbiehl.bsky.social · 09/02/2026
🧪 Publication in @ebiomedicine.bsky.social, project led by @wiebkearlt.bsky.social @mrc-lms.bsky.social & A Prete @unibirmingham.bsky.social with important contributions from @rug.nl theses by @ariadnaalbors.bsky.social , E van den Brandhof, Y Zhang & L Visser www.sciencedirect.com/science/arti...
sciencedirect.com
Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion
Benign adrenal tumours, found in 1–7% of adults, can be non-functioning (NFAT) or show mild autonomous cortisol secretion (MACS), i.e., biochemical co…
054
Reposted by eBioMedicine – The Lancet Discovery Science
MedUni Wien @meduniwien.ac.at · 21/01/2026
🦠 #Hantavirus - How long does the immunity last after a Puumala #virus infection? #MedUniVienna & @medunigraz.at​ investigated the immune responses elicited in Styrian Puumala virus patients. 📰 @ebiomedicine.bsky.social​
meduniwien.ac.at
Hantavirus: Immune response after Puumala virus infection investigated
More about the possible basis for therapy and vaccine!
041
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 20/01/2026
Great overview of where the field stands on henipavirus host-pathogen interactions, and the experimental models helping us study them 🧬🔬 Well done @carroll-lab.bsky.social and team👏 Worth a read 👇
011
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 14/01/2026
📢 Our first issue of 2026 is now live! The latest issue highlights cutting-edge research in gene therapy, immunology, neuroscience, and translational medicine. 🔗 Read the full issue online
eBioMedicine January 2026 cover. The cover depicts scientists on ladders and scaffolds working on a strand of DNA.
112
Reposted by eBioMedicine – The Lancet Discovery Science
Vern Dolinsky @verndolinsky.bsky.social · 06/01/2026
Genetic factors shaping the plasma lipidome and the relations to cardiometabolic risk in children and adolescents @dream-diabetes.bsky.social @ebiomedicine.bsky.social www.thelancet.com/journals/ebi...
022
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 19/12/2025
A new study shows the immune system’s first responders—CD4+ Tfh cells—rapidly activate in draining lymph nodes to drive strong flu vaccine protection across diverse populations 💪💉 @jqsiu.bsky.social and colleagues’ work here: doi.org/10.1016/j.eb...
Human lymph node, cross-section, artwork. Image copyright PIXOLOGICSTUDIO – Getty Images
010
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 17/12/2025
There is a growing need for non-opioid pharmaceutical alternatives for effective chronic pain treatment @laurahuckins.bsky.social @kjohnst9.bsky.social et al. developed a novel genetics-informed framework for drug repurposing, leveraging existing genetic and transcriptomic data resources 💊🧬
Colorful pills and capsules on blue background. Image copyright Tania Ivanova – Getty Images.
110
Reposted by eBioMedicine – The Lancet Discovery Science
WEHI (The Walter and Eliza Hall Institute of Medical Research) @wehi-research.bsky.social · 17/12/2025
A new study by WEHI and MSD researchers has unveiled a first-in-class antimalarial drug candidate that targets two essential parasite enzymes across multiple life stages. Published in @ebiomedicine.bsky.social www.wehi.edu.au/news/new-ant...
A mosquito is pictured in silhouette. The headline reads "First-in-class drug candidate offers hope in malaria fight"
031
Reposted by eBioMedicine – The Lancet Discovery Science
Kristin Kaduk @kristinkaduk.bsky.social · 13/12/2025
Thrilled to share our paper is out now in @ebiomedicine.bsky.social 🥳 The interoception accuracy part is still my favorite 🤩 Have a look: www.thelancet.com/journals/ebi...
053
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 10/12/2025
Between 2006–2008, swine abattoir workers developed a nerve disorder linked to inhaled porcine neural tissue. 🐖🧠A new study identifies synaptophysin-IgG & GAP43-IgG as key biomarkers, also seen in non-exposed patients with a treatable inflammatory polyradiculoneuropathy #autoimmunity #neuropathy 🔗⬇️
100
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 10/12/2025
The December 2025 issue of eBioMedicine is now live! On this month’s cover: 🧑‍⚕️ The accelerating pace of ALS research 🔬 AI-driven immune profiling from histopathology slides to predict chemo-radiotherapy outcomes in rectal cancer 🏘️☀️ Age and livability in a hotter climate
thelancet.com
eBioMedicine, December 2025, Volume 122
Read the current issue of EBioMedicine
000
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 08/12/2025
Senior Editor at eBioMedicine Rida Ansari (@ridaansari.bsky.social) is looking forward to attending @britishneuro.bsky.social #neuroscience Festive Symposium in London, and welcomes queries from attendees! Learn more about our scope and global reach & impact here: hubs.li/Q03BLdg_0
Promotional card. Contact Rida Ansari regarding content enquiries at rida.ansari@lancet.com. Copyright: Elsevier Ltd.
022
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 14/11/2025
Senior Editor at eBioMedicine, Rida Ansari (@ridaansari.bsky.social), is looking forward to attending @crick.ac.uk Translational Research Symposium in London, and welcomes queries from attendees!💡🧪 Learn more about our scope and global reach & impact here: hubs.li/Q03BLdg_0
Promotional card. Contact Rida Ansari regarding content enquiries at rida.ansari@lancet.com. Copyright: Elsevier Ltd.
001
eBioMedicine – The Lancet Discovery Science @ebiomedicine.bsky.social · 02/09/2025
A relatively new class of insecticide called “spatial emanators” offer protection from mosquito-borne diseases such as malaria, dengue, West Nile, yellow fever, and Zika. This meta-analysis of more than 25 years of research provides clarity on how to test these products and how well they work.
thelancet.com
Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis
VPSRs offer protection from contact with mosquitoes, with semi-field studies reflecting field data and species-level differences observed. HLC provided the best quality data. Additional field studies ...
011